References
Kelty CJ, Falk GL (2011) Anti-reflux surgery does not remove cancer risk in Barrett’s esophagus. Surg Endosc 25. doi:10.1007/s00464-011-1748-4
Lenglinger J, Riegler M (2010) Radiofrequency ablation if Barrett’s esophagus persists after fundoplication? Surg Endosc 24:2363–2364
Ciovica R, Riedl O, Neumayer C, Lechner W, Schwab GP, Gadenstätter M (2009) The use of medication after laparoscopic antireflux surgery. Surg Endosc 23:1938–1946
Iascone C, DeMeester TR, Little AG, Skinner DB (1983) Assessment, proposed pathogenesis and surgical therapy. Arch Surg 118:543–549
Vaezi MF, Richter JF (1996) Role of acid and duodenogastro-oesophageal reflux in gastro-oesophageal reflux disease. Gastroenterology 111:1192–1199
Riddell RH, Odze RD (2009) Definition of Barrett’s esophagus: time for a rethink—is intestinal metaplasia dead? Am J Gastroenterol 104:2588–2594
Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS (2000) Is there publication bias in the reporting of cancer risk in Barrett’s esophagus? Gastroenterology 119:333–338
Reid BJ, Li X, Galipeau PC, Vaughan TL (2010) Barrett’s oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer 10:87–101
Curvers WL, ten Kate FJ, Krishnadath KK, Visser M, Elzer B, Baak LC, Bohmer C, Mallant-Hent RC, van Oijen A, Naber AH, Scholten P, Busch OR, Blaauwgeers HG, Meijer GA, Bergman JJ (2010) Low-grade dysplasia in Barrett’s esophagus: overdiagnosed and underestimated. Am J Gastroenterol 105:1523–1530
Wani S, Puli SR, Shaheen NJ, Westhoff B, Slehria S, Bansal A, Rastogi A, Sayana H, Sharma P (2009) Esophageal adenocarcinoma in Barrett’s esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am J Gastroenterol 104:502–513
Disclosure
A. Hussain and S. El-Hasani have no conflicts of interest or financial ties to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hussain, A., El-Hasani, S. Effective antireflux surgery and radiofrequency ablation cannot guarantee complete elimination of lower esophageal adenocarcinoma. Surg Endosc 25, 3949–3950 (2011). https://doi.org/10.1007/s00464-011-1783-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-011-1783-1